XML 111 R82.htm IDEA: XBRL DOCUMENT v3.25.4
Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&D Classified by Nature (Details) - USD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Research And Developments Expense Abstract      
Amortization of intangible assets $ 5,079,839 $ 5,923,389 $ 4,804,768
Analysis and storage 5,302 52,660
Commissions and royalties 14,179 16,257
Import and export expenses 855
Depreciation of leased assets 54,505 68,321
Depreciation of property, plant and equipment 767,731 618,627 637,734
Freight and haulage 2,025 30,450 17,707
Employee benefits and social securities 4,032,386 4,727,340 4,781,678
Insurance 49,343 48,872 78,673
Energy and fuel 5,576 8,101 111,481
Maintenance 236,867 283,895 475,868
Supplies and materials 2,731,604 2,361,380 3,078,403
Licenses & Patents 516,591 67,188 181,264
Mobility and travel 141,481 205,741 245,875
Publicity and advertising 23,383
Systems expenses 40,286 29,026 31,410
Vehicles expenses 16,858 30,883 8,252
Share-based incentives 217,494 510,162 136,754
Surveillance expenses 11,145
Professional fees and outsourced services 878,973 1,325,361 550,585
Professional fees related parties 90,533 256,877 542,551
Office supplies 261,263 696,760 111,618
Miscellaneous 976 269,750 128
Total 15,138,510 17,422,487 15,943,987
R&D capitalized (Note 8.3) 8,614,448 11,856,331 10,753,047
R&D profit and loss 15,138,510 17,422,487 15,943,987
Total $ 23,752,958 $ 29,278,818 $ 26,697,034